Prognostic significance of C-MYC dysregulation in esophageal squamous cell carcinoma: a meta-analysis.
Conclusion: C-MYC dysregulation is a promising biomarker for ESCC prognosis.
PMID: 32462905 [PubMed - as supplied by publisher]
Source: Future Medicine: Biomarkers in Medicine - Category: Internal Medicine Tags: Biomark Med Source Type: research
More News: Cancer & Oncology | Carcinoma | Databases & Libraries | Esophagus Cancer | Internal Medicine | Science | Skin Cancer | Squamous Cell Carcinoma | Study